Gregory Kazan
About
Gregory Kazan is from Sunset Beach, North Carolina, United States. Gregory works in the following industries: "Research". Gregory is currently Research Associate at Moderna Therapeutics. In Gregory's previous role as a Development Engineer II at Millipore Sigma, EMD Millipore, Gregory worked in Bedford, MA until Apr 2016. Prior to joining Millipore Sigma, EMD Millipore, Gregory was a Research/Biochemical Scientist II at Millipore Corporation and held the position of Research/Biochemical Scientist II at Danvers, MA.
Go to finalscout.com and type Gregory Kazan's name into the search box for a free email address. FinalScout is a professional database with more than 500 million business professionals and 200 million company executives.
Gregory Kazan's current jobs
Gregory Kazan's past jobs
Downstream sterile/ultrafiltration development, scale up, TFF continuous/single pass diafiltration Developed test system and validated Express® and Durapore® single use filter devices Completed OptiScale® 25 scaling validation for Express® family of single use filter devices Completed direct flow scale up validation for Express® high area single use filter devices Developed TFF capsule conditioning and performance test methods Developed TFF test system for 0.1m2 single use spiral capsule diafiltration
Drug Discovery Application Development Led global team to commercialize the 96-well MultiScreen® Solubility Plate Developed applications to commercialize the 96-well MultiScreen® Transport Receiver Plate Produced validated SoftMax Pro ADME protocols for Molecular Devices Corporation Developed improved Western blotting method for new chemiluminescent reagents Trained Analiza, BASF and Fisher customers on ADME methods to foster product credibility Produced/disclosed data to Novartis, Wyeth, Nanostream confirming ADME product performance Developed a sample requisition database to enable efficient testing and save time Upgraded, documented, transferred ultra-filtration protein methods to Molsheim, France Provided applications collateral for 96-well MultiScreen® Ultracel commercialization Developed bead detection technique to qualify luminex bead recovery after vacuum filtration